get real about what ? AGN traded at a 70 million market cap after pre clinical success it’s now trading at a 120 million market cap and about to become a 300 million market cap on phase 2. NYR is in the same space and on phase 2 next year you’re looking at a 100-150 million market cap with upside of 300 million plus market cap. Its identical to its peers
you think its valued less than its funding lol ok you should sell your cash than less it’s worth lol
Ann: NYR Signs Strategic Partnership with US Brain Injury Company, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1642 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 14.40pm 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable